It is nearly seven years since Mylan was left at the altar after an attempted $26 billion hostile takeover of publicly traded pharmaceutical manufacturer Perrigo. But the fallout continues in the courts.  Perrigo’s investors were far from happy with the global healthcare giant and its executive team at the time, since mired in nearly 30 securities actions including a class action for damages brought by investors in the US. The obvious question is who foots the bill for all this litigation? Not Perrigo’s insurers; or at least that’s the position so far. Ten major insurance companies including Chubb, AIG, Allianz, and…

Want to continue reading?

Join today with an Annual membership and get full access to The Currency for just €200 (68c per day) or try monthly membership for just €5 for your first month.

Subscribe

Cancel at any time.

Are you already a member? .